Surgical Menopause: Immediate Hormonal Cessation and Why It Requires a Different Protocol
Surgical menopause occurs when both ovaries are removed (bilateral oophorectomy), causing an immediate, abrupt drop in estrogen, progesterone, and testosterone. Unlike natural menopause, there is no gradual transition. Symptoms can be severe and may require higher hormone doses and more frequent monitoring than natural menopause.
What Makes Surgical Menopause Different
Natural menopause is a gradual process unfolding over 4 to 8 years. Surgical menopause is an immediate event. When both ovaries are removed, estrogen, progesterone, and testosterone production drops to near zero overnight. The brain, bones, cardiovascular system, and urogenital tissues all lose their hormonal support simultaneously, without the adaptive period that natural menopause allows.
Unlike natural menopause, which unfolds over years, surgical menopause happens in hours. Your brain and body are suddenly deprived of the estrogen, progesterone, and testosterone they relied on for decades. This “hormonal shock” requires immediate, higher-dose stabilization to protect bones, brain, and cardiovascular function. This abrupt deprivation is sometimes called a hormonal shock: the brain and body that relied on estrogen for decades suddenly lose it in hours, without any adaptive period. The clinical consequences are more severe than natural menopause: hot flashes are often more intense, bone loss accelerates more rapidly, cardiovascular risk increases more sharply, and cognitive and mood symptoms tend to be more pronounced. Women who undergo surgical menopause before the natural age of menopause face decades of estrogen deficiency that would not otherwise have occurred, significantly increasing long-term health risks if untreated.
The ovaries are responsible for approximately 50% of a woman’s total testosterone production. When they are removed, testosterone levels can drop by half overnight. The loss of “drive,” both sexual and cognitive, can be immediate and profound. Dr. Ashar’s three-hormone protocol, including low-dose testosterone replacement, is essential for surgical menopause patients to restore this missing component that is almost never addressed by the operating surgeon. The ovaries are responsible for approximately 50% of a woman’s total testosterone production. When removed, the “drive”, both sexual and cognitive, can vanish overnight alongside the loss of estrogen and progesterone. Dr. Ashar’s three-hormone approach is essential for surgical menopause: estradiol, progesterone, and testosterone are all replaced. BHRT is the standard of care for women with surgical menopause, particularly those who were premenopausal at the time of surgery. Hormone therapy in these women is not elective symptom management. It is replacement of a physiological function that was removed. Dr. Ashar develops individualized protocols based on the type of surgery performed, the patient’s age at surgery, and current symptom burden.
If only the uterus was removed (hysterectomy without oophorectomy), ovarian hormone production continues and surgical menopause does not occur. However, some evidence suggests the procedure can accelerate ovarian decline by several years, even when the ovaries are retained. Women with hysterectomy but retained ovaries may still experience earlier-than-expected hormonal changes and benefit from monitoring.
Required labs: Estradiol, total and free testosterone, FSH, LH (often markedly elevated post-oophorectomy), SHBG, TSH, and comprehensive metabolic panel. Women without a uterus do not require progesterone for endometrial protection, but may still benefit from micronized progesterone for sleep and mood.
Common Questions
It depends on whether your ovaries were also removed. If only the uterus was removed and the ovaries were retained, hormone production continues and surgical menopause has not occurred. If both ovaries were removed, you are in surgical menopause and BHRT is the standard of care, particularly for women under the natural age of menopause. The recommendation to avoid hormones is often a holdover from the misapplication of the 2002 WHI study to all women, which current guidelines have substantially revised.
Often yes, particularly for women who were premenopausal at the time of surgery. The abruptness of the hormonal loss and the longer duration of potential deficiency may require higher initial doses to achieve symptom control. Dr. Ashar titrates dosing based on your labs, symptom response, and age at surgery.
Progesterone is required in standard BHRT to protect the endometrial lining from unopposed estrogen. Without a uterus, this indication does not apply. However, micronized progesterone may still be prescribed for its neuroprotective and sleep-stabilizing benefits via GABA receptor activity and mood stabilization. This is a clinical decision made at consultation based on your specific symptoms.
Specialized Protocols for Surgical Menopause
Free consultation with Dr. Ashar. Individualized protocol based on your surgical history.
Not sure if your symptoms are hormonal?
Our free menopause assessment takes about three minutes. Answer 11 questions and get a read on whether your symptoms fit perimenopause or menopause, and which labs help confirm it.
Take the free assessment →Educational screening, not a diagnosis. Only a provider can confirm.